SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)

Diffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and account for about 5% of all primary brain tumors. Treatment strategies for these low-grade gliomas in adults have recently changed. The 2016 World Health Organization (WHO) classification has updated the definiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepúlveda-Sánchez, J. M., Muñoz Langa, J., Arráez, M. Á., Fuster, J., Hernández Laín, A., Reynés, G., Rodríguez González, V., Vicente, E., Vidal Denis, M., Gallego, Ó.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785601/
https://www.ncbi.nlm.nih.gov/pubmed/29124520
http://dx.doi.org/10.1007/s12094-017-1790-3
_version_ 1783295630842527744
author Sepúlveda-Sánchez, J. M.
Muñoz Langa, J.
Arráez, M. Á.
Fuster, J.
Hernández Laín, A.
Reynés, G.
Rodríguez González, V.
Vicente, E.
Vidal Denis, M.
Gallego, Ó.
author_facet Sepúlveda-Sánchez, J. M.
Muñoz Langa, J.
Arráez, M. Á.
Fuster, J.
Hernández Laín, A.
Reynés, G.
Rodríguez González, V.
Vicente, E.
Vidal Denis, M.
Gallego, Ó.
author_sort Sepúlveda-Sánchez, J. M.
collection PubMed
description Diffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and account for about 5% of all primary brain tumors. Treatment strategies for these low-grade gliomas in adults have recently changed. The 2016 World Health Organization (WHO) classification has updated the definition of these tumors to include their molecular characterization, including the presence of isocitrate dehydrogenase (IDH) mutation and 1p/19p codeletion. In this new classification, the histologic subtype of grade II-mixed oligoastrocytoma has also been eliminated. The precise optimal management of patients with low-grade glioma after resection remains to be determined. The risk–benefit ratio of adjuvant treatment must be weighed for each individual.
format Online
Article
Text
id pubmed-5785601
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-57856012018-02-01 SEOM clinical guideline of diagnosis and management of low-grade glioma (2017) Sepúlveda-Sánchez, J. M. Muñoz Langa, J. Arráez, M. Á. Fuster, J. Hernández Laín, A. Reynés, G. Rodríguez González, V. Vicente, E. Vidal Denis, M. Gallego, Ó. Clin Transl Oncol Clinical Guides in Oncology Diffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and account for about 5% of all primary brain tumors. Treatment strategies for these low-grade gliomas in adults have recently changed. The 2016 World Health Organization (WHO) classification has updated the definition of these tumors to include their molecular characterization, including the presence of isocitrate dehydrogenase (IDH) mutation and 1p/19p codeletion. In this new classification, the histologic subtype of grade II-mixed oligoastrocytoma has also been eliminated. The precise optimal management of patients with low-grade glioma after resection remains to be determined. The risk–benefit ratio of adjuvant treatment must be weighed for each individual. Springer International Publishing 2017-11-09 2018 /pmc/articles/PMC5785601/ /pubmed/29124520 http://dx.doi.org/10.1007/s12094-017-1790-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Guides in Oncology
Sepúlveda-Sánchez, J. M.
Muñoz Langa, J.
Arráez, M. Á.
Fuster, J.
Hernández Laín, A.
Reynés, G.
Rodríguez González, V.
Vicente, E.
Vidal Denis, M.
Gallego, Ó.
SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
title SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
title_full SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
title_fullStr SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
title_full_unstemmed SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
title_short SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
title_sort seom clinical guideline of diagnosis and management of low-grade glioma (2017)
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785601/
https://www.ncbi.nlm.nih.gov/pubmed/29124520
http://dx.doi.org/10.1007/s12094-017-1790-3
work_keys_str_mv AT sepulvedasanchezjm seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT munozlangaj seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT arraezma seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT fusterj seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT hernandezlaina seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT reynesg seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT rodriguezgonzalezv seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT vicentee seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT vidaldenism seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017
AT gallegoo seomclinicalguidelineofdiagnosisandmanagementoflowgradeglioma2017

Ejemplares similares